N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.
about
Interpatient variability in dexmedetomidine response: a survey of the literatureModifications of the 7-Hydroxyl Group of the Transthyretin Ligand Luteolin Provide Mechanistic Insights into Its Binding Properties and High Plasma SpecificityTales from the war on error: the art and science of curating QSAR data.LC-MS/MS quantification of sulfotransferases is better than conventional immunogenic methods in determining human liver SULT activities: implication in precision medicine.Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 AgonistsGlucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10Dissimilarities in the metabolism of antiretroviral drugs used in HIV pre-exposure prophylaxis in colon and vagina tissues.In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract.Substrate inhibition kinetics in drug metabolism reactions.Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.Metabolic and toxicological considerations of botanicals in anticancer therapy.Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions.Oxidative stress in apoptosis and cancer: an update.Transcriptional regulation of human UDP-glucuronosyltransferase genes.Diastereoselective and enantioselective conjugate addition reactions utilizing α,β-unsaturated amides and lactams.Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme Inhibition.Progress in Prediction and Interpretation of Clinically Relevant Metabolic Drug-Drug Interactions: a Minireview Illustrating Recent Developments and Current Opportunities.Elucidation of in vitro phase I metabolites of droperidol using UPLC-QTOF MS.Antibacterial activity of resazurin-based compounds against Neisseria gonorrhoeae in vitro and in vivo.Identifying and applying a highly selective probe to simultaneously determine the O-glucuronidation activity of human UGT1A3 and UGT1A4.In vitro glucuronidation of aprepitant: a moderate inhibitor of UGT2B7.Glucuronidation of drugs in humanized UDP-glucuronosyltransferase 1 mice: Similarity with glucuronidation in human liver microsomes.Significantly decreased and more variable expression of major CYPs and UGTs in liver microsomes prepared from HBV-positive human hepatocellular carcinoma and matched pericarcinomatous tissues determined using an isotope label-free UPLC-MS/MS method.Human microbiome signatures of differential colorectal cancer drug metabolism.Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk.Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation.Characterizing the in vitro species differences in N-glucuronidation of a potent pan-PIM inhibitor GNE-924 containing a 3,5-substituted 6-azaindazole.Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations.The metabolism of trifluoperazine (TFP) exhibits atypical kinetic behavior in both human liver microsomes (HLMs) and monkey liver microsomes (MyLM).Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine.Impact of enzymatic hydrolysis on the quantification of total urinary concentrations of chemical biomarkers.Posttranscriptional regulation of UGT2B10 hepatic expression and activity by alternative splicing.Molecular docking-based design and development of a highly selective probe substrate for UDP-glucuronosyltransferase 1A10.In vitro inhibition of UGT1A3, UGT1A4 by ursolic acid and oleanolic acid and drug-drug interaction risk prediction.Discovery of a novel trimebutine metabolite and its impact on N-desmethyltrimebutine quantification by LC-MS/MS.N-3 Polyunsaturated Fatty Acids Stimulate Bile Acid Detoxification in Human Cell Models.Uridine 5'-diphospho-glucronosyltrasferase: Its role in pharmacogenomics and human disease.
P2860
Q26994769-4E92E6C8-BE7A-4BA8-8069-4CDFBDE41368Q28551199-3A0FB721-7B62-46CD-93DB-E4F3C1A7A671Q30988299-8C1C56AA-07D9-4522-8731-9C464F78F70CQ33818825-96844147-3037-401E-ACF9-FC2F8393B65EQ34518566-E3629E16-6DE0-4B0A-9351-994C1C3B25E8Q35745226-0635B5A4-C860-4FF4-A5E5-E867080D3EFBQ37253552-EA3A1BC7-FC64-4F50-8531-58A942D81BECQ37665619-0866F7E0-C216-4B24-BE51-DAD8C0E94159Q37941118-85C78D37-A5FF-4564-9E3A-5B32CEC1B1C7Q37990054-1FF05EA7-BE21-43E2-BD1D-63F1B3968FB8Q38006050-E587BE09-2B66-4D28-8231-6F694E863203Q38008438-352C7E3F-C3F0-4B3C-921F-EA60458004F4Q38027434-695D73AC-A820-499F-877A-2DF92FE6A3B8Q38261875-D2AA5970-A222-4246-912B-5A15239B2E26Q38482449-D96DBB55-87E1-4B79-8913-51838A083C72Q38811693-1C5FFA6C-4D7B-4BB7-A007-6CCD0E05F748Q38928302-4F770FE6-EF32-4BD8-9DA6-883BB5261476Q39240235-2BF3A0A4-A803-4C40-9CCD-0468C5577D73Q39566214-4B015FFF-A419-47FD-9084-955711CFA33FQ39736342-83901B4B-33F1-4130-9061-59835E3CD5CBQ40600601-120BE3DF-8F9C-4D99-9ECE-9691EF3860E2Q41692521-549DC86B-8543-4D82-A46E-15F4BDEBB71EQ42184370-F7E7C579-E685-4546-9563-11E2F859D092Q42958061-E8C1665B-89CD-4F05-9383-150F410096BBQ43435543-1499860C-A378-4C37-9522-82EACC6395AFQ43531574-D48620A0-658D-4DB7-8669-76BE4F8CD931Q46315733-1475209F-0C70-47BB-B47F-624F7AB57663Q46837567-0E2E22A2-126F-4A73-8B6A-7C0FCFA82A49Q46955249-9B8392FF-E269-40C4-B5D4-3FECE9ABDFC0Q47907013-D147933E-CE49-400F-BF25-441335219662Q49967726-8EE7072C-9637-4D4E-8461-510F1C9481AFQ50024661-3325311B-39EA-419B-9CB2-0C6904978B9DQ50109862-D09A8F67-90FF-4511-88FB-C34AD2F41958Q51531478-11746E68-B25D-4F7F-AE89-D528F2872493Q53172550-301B95CC-1408-4F9D-90A6-61D82B763995Q55020611-831BCC02-12B2-495A-A4C6-CA84F53F38B4Q55146337-8E9E53F3-B96E-4AF4-BDFF-96426E1446EB
P2860
N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
N-glucuronidation of drugs and ...... UDP-glucuronosyltransferases.
@en
N-glucuronidation of drugs and ...... UDP-glucuronosyltransferases.
@nl
type
label
N-glucuronidation of drugs and ...... UDP-glucuronosyltransferases.
@en
N-glucuronidation of drugs and ...... UDP-glucuronosyltransferases.
@nl
prefLabel
N-glucuronidation of drugs and ...... UDP-glucuronosyltransferases.
@en
N-glucuronidation of drugs and ...... UDP-glucuronosyltransferases.
@nl
P2093
P2860
P1433
P1476
N-glucuronidation of drugs and ...... UDP-glucuronosyltransferases.
@en
P2093
Mikko Koskinen
Moshe Finel
Sanna Kaivosaari
P2860
P304
P356
10.3109/00498254.2011.563327
P407
P577
2011-03-24T00:00:00Z